LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%)

Medical Device Investing

LeMaitre Vascular (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27% dividend increase to $0.07/share. As quoted in the press release: Record sales of $26.2mm, +12% vs. Q4 2016 Record operating income of $6.3mm vs. $3.9mm, +62% Net income of $4.3mm vs. $2.6mm, +65% Earnings of $0.21 per diluted …

LeMaitre Vascular (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27% dividend increase to $0.07/share.

As quoted in the press release:

Record sales of $26.2mm, +12% vs. Q4 2016
Record operating income of $6.3mm vs. $3.9mm, +62%
Net income of $4.3mm vs. $2.6mm, +65%
Earnings of $0.21 per diluted share vs. $0.13, +60%
Record EBITDA of $7.4mm vs. $4.8mm, +55%

Click here to read the full press release.

dividend guidance lemaitre vascular q4 2016 Medical Device Investing